41
TITLE: p53 binding to the p21 promoter is dependent on the nature of DNA damage
AUTHORS: Ewelina Bodzak; Michael D Blough; Patrick W.K Lee; Richard Hill;
PUBLISHED: 2008, SOURCE: Cell Cycle, VOLUME: 7, ISSUE: 16
INDEXED IN: CrossRef: 47
IN MY: ORCID
42
TITLE: Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-α and the transcriptional repressor PLZF
AUTHORS: Buluwela L.; Pike J.; Mazhar D.; Kamalati T.; Hart S.M.; Al-Jehani R.; Yahaya H.; Patel N.; Sarwarl N.; Heathcote D.A.; Schwickerath O.; Phoenix F.; Hill R.; Aboagye E.; Shousha S.; Waxman J.; Lemoine N.R.; Zelent A.; Coombes R.C.; Simak Ali;
PUBLISHED: 2005, SOURCE: Gene Therapy, VOLUME: 12, ISSUE: 5
INDEXED IN: Scopus CrossRef: 12
IN MY: ORCID
43
TITLE: Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy
AUTHORS: Hallden, G; Hill, R; Wang, Y; Anand, A; Liu, TC; Lemoine, NR; Francis, J; Hawkins, L; Kirn, D;
PUBLISHED: 2003, SOURCE: Molecular Therapy, VOLUME: 8, ISSUE: 3
INDEXED IN: Scopus
IN MY: ORCID
44
TITLE: E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models  Full Text
AUTHORS: Wang, Y; Hallden, G; Hill, R; Anand, A; Liu, TC; Francis, J; Brooks, G; Lemoine, N; Kirn, D;
PUBLISHED: 2003, SOURCE: Nature Biotechnology, VOLUME: 21, ISSUE: 11
INDEXED IN: Scopus CrossRef
IN MY: ORCID
Page 5 of 5. Total results: 44.